BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Theratechnologies Presents New In Vivo Pre-Clinical Data at AACR Demonstrating Significant Anti-Tumor Activity of TH1902 in All Studied Cancer TypesTH1902 anti-tumor post-treatment effect persists longer than with docetaxel alone

  Theratechnologies Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies, announced that new in vivo preclinical data were presented at the 2021 Annual Meeting of the American Association for Cancer Research.

  April 10, 2021

   · 

  8 min read
• Drug Development

  Mirati Therapeutics Presents Preclinical Data on Novel Approach to PRMT5 Inhibition that Selectively Targets the PRMT5/MTA Complex in MTAP-Deleted Cancer Models

  Internally discovered PRMT5 program represents a potential first-in-class approach to specifically target MTAP-deleted tumors Anticipate filing an Investigational New Drug application in the first half of 2022

  April 10, 2021

   · 

  5 min read